Succesful Strategies against Counterfeiting in the Pharma and Chemical Industry

The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. 

Our annual Pharma Trends Outlook report delves into the critical challenges facing the pharmaceutical supply chain in 2024. From protecting against supply shortages, quality management maturity, and cross-industry collaboration for sustainability and patient-centred initiatives, the pharmaceutical industry must contend with the increasing need to digitise operations with generative AI and machine-learning technologies, or risk being left behind in a changing world. In partnership with Arvato Systems, the CPHI Online 2024 Pharma Trends Outlook dissects emerging trends for 2024 with expert insight providing valuable perspectives on the rapidly changing pharmaceutical landscape. 12 Pharma Trends for 2024 Supply chain digitisation with generative AI Pharmaceutical packaging innovations Quality Management Maturity Emerging biotech and R&D outsourcing trends Collaboration for sustainability goals Excipient development and manufacturing Balancing drug pricing, manufacturing costs, and patient access Science-backed evidence for herbal medicines Accelerating B2B pharma marketing Alzheimer's research What 2023 drug approvals mean for 2024 An emerging Market: Middle East, Saudi Arabia, and beyond

Arvato Systems is a new member of the German Association of Pharmaceutical Manufacturers (BAH). The BAH is considered the strongest trade association in Germany's pharmaceutical industry in terms of membership. As a provider of digital solutions in the pharmaceutical industry, Arvato Systems will now also be involved in the BAH's large partner network.